Skip to content
HowShorted

Arcadia Biosciences, Inc. short interest in 2025

In 2025, Arcadia Biosciences, Inc.'s disclosed short interest ran from 1.00% of shares outstanding on 15 Jan 2025 to 1.57% on 31 Dec 2025, a change of +0.57 percentage points. The year's high was 9.49% on 31 Oct 2025 and its low 0.54% on 31 Jan 2025, averaging 1.97% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.25 days on 15 Aug 2025. Full history: Arcadia Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcadia Biosciences, Inc. in 2025

2025 in figures

Start of year
1.00% (15 Jan 2025)
End of year
1.57% (31 Dec 2025)
Change
+0.57 pp
High
9.49% (31 Oct 2025)
Low
0.54% (31 Jan 2025)
Average
1.97%
Highest days to cover
9.25 (15 Aug 2025)
SEC filings marked
8

Every report in 2025

Arcadia Biosciences, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20251.00%1.00
31 Jan 20250.54%1.00
14 Feb 20251.10%2.56
28 Feb 20250.91%2.05
14 Mar 20250.75%2.69
31 Mar 20250.98%2.82results (8-K), 10-K filed
15 Apr 20250.97%1.47
30 Apr 20250.90%1.00
15 May 20251.42%1.4610-Q filed, results (8-K)
30 May 20250.97%1.00
13 Jun 20251.63%1.68
30 Jun 20251.69%1.28
15 Jul 20251.61%1.18
31 Jul 20251.51%3.52
15 Aug 20251.80%9.2510-Q filed, results (8-K)
29 Aug 20250.79%1.59
15 Sep 20251.11%1.00
30 Sep 20250.95%2.45
31 Oct 20259.49%1.12
14 Nov 20256.91%3.4310-Q filed, results (8-K)
28 Nov 20253.77%3.82
15 Dec 20253.05%3.73
31 Dec 20251.57%1.00

See also: Arcadia Biosciences, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.